Posts by: Alice Melão

News

A protein called CD151 is highly expressed on the surface of high-grade serous carcinoma (HGSC) cells, the most common and lethal subtype of ovarian cancers, recent research found. Expression of this ... Read more

January 27, 2017February 20, 2017

Metabolic Enzyme Could Be the Answer to Using Lynparza in Broad Range of Tumors

News

Cancer cells often change their metabolism to support their fast growing rate. Researchers have now found that an enzyme involved in this mechanism, called PGAM1, is also required to activate DNA ... Read more

November 28, 2016

New InFlo Computer Method Predicts Cancer Cell Activity, Identifies Biomarkers

News

A new computed-based method called InFlo assesses cellular communication networks and identifies disease-specific network anomalies that can cause cancer and other diseases. This new tool may facilitate the discovery of ... Read more

September 28, 2016September 28, 2016

Phase 1 Study of Treatment for Advanced HER2-Positive Cancers Gets Underway

News

A Phase 1 clinical trial assessing the safety and efficacy of the anti-HER2 antibody ZW25 in advanced or metastatic HER2-positive cancers has just dosed its first patient, according to a recent ... Read more